Candriam Equities L Oncology Fund Class CH EUR Cap
Investment Fund – Candriam – NAV History & Analysis
214.22 EUR
NAV as of 18/03/2026
Candriam Equities L Oncology Fund Class CH EUR Cap
214.22
EUR
Candriam
NAV history of Candriam Equities L Oncology Fund Class CH EUR Cap
NAV history of Candriam Equities L Oncology Fund Class CH EUR Cap
Performance & Momentum
6 Months
15.41 %
1 Year
14.22 %
3 Years
11.99 %
5 Years
3.67 %
Risk (SRRI)
4/7
Management fee
0.016%
PEA eligible
No
Last update
18/03/2026
Similar Funds
Track your funds
with precision
With Investor and Expert plans, track your funds in your portfolios and benefit from AI analysis, correlation metrics, and momentum scoring on this asset class.
- Multi-asset portfolio tracking (stocks, ETFs, funds)
- Momentum and correlation analysis
- AI-powered investment insights
